SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 117 filers reported holding SYNDAX PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,883,000 | -30.6% | 1,025,000 | 0.0% | 6.13% | -41.6% |
| Q2 2023 | $21,453,250 | -0.9% | 1,025,000 | 0.0% | 10.51% | +0.9% |
| Q1 2023 | $21,648,000 | -17.0% | 1,025,000 | 0.0% | 10.42% | -39.5% |
| Q4 2022 | $26,086,250 | +5.9% | 1,025,000 | 0.0% | 17.22% | +5.3% |
| Q3 2022 | $24,631,000 | +24.9% | 1,025,000 | 0.0% | 16.36% | +16.2% |
| Q2 2022 | $19,721,000 | +10.7% | 1,025,000 | 0.0% | 14.07% | +46.3% |
| Q1 2022 | $17,815,000 | -20.6% | 1,025,000 | 0.0% | 9.61% | +21.5% |
| Q4 2021 | $22,437,000 | +14.5% | 1,025,000 | 0.0% | 7.92% | +102.7% |
| Q3 2021 | $19,588,000 | +11.3% | 1,025,000 | 0.0% | 3.91% | +38.6% |
| Q2 2021 | $17,599,000 | -23.2% | 1,025,000 | 0.0% | 2.82% | -31.7% |
| Q1 2021 | $22,919,000 | +0.5% | 1,025,000 | 0.0% | 4.12% | +5.4% |
| Q4 2020 | $22,796,000 | +50.7% | 1,025,000 | 0.0% | 3.92% | -19.0% |
| Q3 2020 | $15,129,000 | -0.4% | 1,025,000 | 0.0% | 4.83% | -16.6% |
| Q2 2020 | $15,191,000 | +58.3% | 1,025,000 | +17.1% | 5.80% | +38.6% |
| Q1 2020 | $9,599,000 | – | 875,000 | – | 4.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 3,600,000 | $52,272,000 | 8.55% |
| Foresite Capital Management IV, LLC | 875,000 | $12,705,000 | 7.06% |
| Aisling Capital Management LP | 1,025,000 | $14,883,000 | 6.13% |
| Saturn V Capital Management LP | 807,969 | $11,731,710 | 4.91% |
| Eversept Partners, LP | 2,596,245 | $37,697,477 | 3.19% |
| ACUTA CAPITAL PARTNERS, LLC | 297,035 | $4,312,948 | 2.89% |
| Paradigm Biocapital Advisors LP | 2,390,077 | $34,703,918 | 2.36% |
| DAFNA Capital Management LLC | 458,373 | $6,655,576 | 2.07% |
| SPHERA FUNDS MANAGEMENT LTD. | 773,061 | $11,224,846 | 2.04% |
| PFM Health Sciences, LP | 2,715,235 | $39,425,212 | 1.86% |